Alternatives in the management of osteoradionecrosis of the jaw: case report

Authors

DOI:

https://doi.org/10.24265/kiru.2025.v22n1.05

Keywords:

Osteoradionecrosis; Hyperbaric Oxygenation; Tetracyclines; Platelet-Rich Fibrin

Abstract

Osteoradionecrosis is a devastating pathology because it affects the patient's quality of life, which is characterized by the presence of bone sequestration in an area that was previously exposed to oncological radiotherapy treatment. Currently there are different protocols as therapeutic alternatives; Hyperbaric oxygen therapy, the use of platelet-rich fibrin and tetracycline-induced fluorescence. Therefore, the objective of this report is to show a case of mandibular osteoradionecrosis where different therapeutic alternatives are used.

Downloads

Download data is not yet available.

Author Biographies

  • Juan Pablo Macias Angulo , Universidad de Guadalajara, Guadalajara, México

    Cirujano dentista

  • Jonathan Alexis Grajeda Cruz , 2Instituto Jalisciense de Cancerología, Zapopan, México

    Especialista en Cirugía Oral y Maxilofacial

References

Chamoli A, Gosavi AS, Shirwadkar UP, Wangdale KV, Behera SK, Kurrey NK, et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121(105451):105451. doi: 10.1016/j.oraloncology.2021.105451.

International Agency for Research on Cancer (FR). Absolute numbers, Incidence and Mortality, Both sexes, in 2022. World Health Organization. Lyon: 2022.

Gelband H, Jha, P, Sankaranarayanan R, Horton S. Disease control priorities. 3ra ed. Vol. 3. Washington (DC). The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1.

Khoo SC, Nabil S, Fauzi AA, Yunus SSM, Ngeow WC. Predictors of osteoradionecrosis following irradiated tooth extraction. Radiat Oncol. 2021;16(1):130. doi: 10.1186/s13014-021-01851-0

Nadella KR, Kodali RM, Guttikonda LK, Jonnalagadda A. Osteoradionecrosis of the jaws: Clinico-therapeutic management: A literature review and update. J Maxillofac Oral Surg. 2015;14(4):891–901. doi: 10.1007/s12663-015-0762-9

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM. The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: A Dana-Farber/Brigham and Women’s Cancer Center multidisciplinary guideline. Oncologist. 2017;22(3):343–50. doi: 10.1634/theoncologist.2016-0298

Ristow O, Otto S, Geiß C, Kehl V, Berger M, Troeltzsch M, et al. Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. Int J Oral Maxillofac Surg. 2017;46(2):157–66. doi: 10.1016/j.ijom.2016.10.008

Pavlovic V, Ciric M, Jovanovic V, Trandafilovic M, Stojanovic P. Platelet-rich fibrin: Basics of biological actions and protocol modifications. Open Med. 2021;16(1):446–54. doi: 10.1515/med-2021-0259

Marx RE. Oral and Maxillofacial Pathology. 2a ed. Vol. 2. Miami: Quintessence Publishing; 2012. 1008 p.

Roco-Bazáez J, Pinto-Galleguillos A, Dethlefs-Canto J. Resección Ósea Guiada por Fluorescencia en Pacientes con Osteonecrosis Mandibular Asociada a Medicamentos: Scoping Review. Int J Odontostomatol. 2022;16(2):321–30. doi: 10.4067/s0718-381x2022000200321

Harris P, Durand R, Schmittbuhl M, Kabir R. Platelet-rich fibrin as a treatment option for osteoradionecrosis: A literature review. J Stomatol Oral Maxillofac Surg. 2022;123(3):e207. doi: 10.1016/j.jormas.2021.06.005

Published

2025-04-08

Issue

Section

Reportes de casos/ Case reports

How to Cite

Alternatives in the management of osteoradionecrosis of the jaw: case report. (2025). Revista KIRU ISSN (Impreso): 1812 - 7886 ISSN (Digital): 2410-2717, 22(1), 28-32. https://doi.org/10.24265/kiru.2025.v22n1.05

Similar Articles

1-10 of 16

You may also start an advanced similarity search for this article.